Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.

Harries AD, Kumar AMV, Satyanarayana S, Takarinda KC, Timire C, Dlodlo RA.

Expert Rev Respir Med. 2019 Nov 25:1-14. doi: 10.1080/17476348.2020.1694907. [Epub ahead of print]


Can visual interpretation of NucliSens graphs reduce the need for repeat viral load testing?

Handireketi N, Timire C, Shewade HD, Munemo E, Nyagupe C, Chipuka S, Sisya L, Gumbo H, Dhitima E, Harries AD.

PLoS One. 2019 Nov 20;14(11):e0223597. doi: 10.1371/journal.pone.0223597. eCollection 2019.


Better care for babies: the added value of a modified reverse syphilis testing algorithm for the treatment of congenital syphilis in a maternity Hospital in Central African Republic.

Ogundipe OF, Van den Bergh R, Thierry B, Takarinda KC, Muller CP, Timire C, Caluwaerts S, Chaillet P, Zuniga I.

BMC Pediatr. 2019 Aug 15;19(1):284. doi: 10.1186/s12887-019-1622-4.


HIV Viral Load Estimation Using Hematocrit Corrected Dried Blood Spot Results on a BioMerieux NucliSENS® Platform.

Nyagupe C, Shewade HD, Ade S, Timire C, Tweya H, Vere N, Chipuka S, Sisya L, Gumbo H, Ditima E, Zinyowera S.

Diagnostics (Basel). 2019 Jul 30;9(3). pii: E86. doi: 10.3390/diagnostics9030086.


Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.

Timire C, Metcalfe JZ, Chirenda J, Scholten JN, Manyame-Murwira B, Ngwenya M, Matambo R, Charambira K, Mutunzi H, Kalisvaart N, Sandy C.

Int J Infect Dis. 2019 Oct;87:119-125. doi: 10.1016/j.ijid.2019.07.021. Epub 2019 Jul 27.


'I am on treatment since 5 months but I have not received any money': coverage, delays and implementation challenges of 'Direct Benefit Transfer' for tuberculosis patients - a mixed-methods study from South India.

Nirgude AS, Kumar AMV, Collins T, Naik PR, Parmar M, Tao L, Akshaya KM, Raghuveer P, Yatnatti SK, Nagendra N, Nagaraja SB, Habeena S, Mn B, Rao R, Shastri S.

Glob Health Action. 2019;12(1):1633725. doi: 10.1080/16549716.2019.1633725.


Neglected tropical diseases and the sustainable development goals: an urgent call for action from the front line.

Addisu A, Adriaensen W, Balew A, Asfaw M, Diro E, Garba Djirmay A, Gebree D, Seid G, Begashaw H, Harries AD, Hirpa Adugna A, Ayalew Jejaw Z, Kamau EM, Kelbo T, Manzi M, Medebo Daniel D, Moloo A, Olliaro P, Owiti P, Reeder JC, Senkoro M, Takarinda K, Terry R, Timire C, Tucho S, Tweya H, Wendemagegn Y, Verdonck K, Vogt F, van Henten S, van Griensven J, Worku B, Zolfo M, Zachariah R; Ethiopia SORT IT Neglected Tropical Diseases Group.

BMJ Glob Health. 2019 Feb 8;4(1):e001334. doi: 10.1136/bmjgh-2018-001334. eCollection 2019. No abstract available. Erratum in: BMJ Glob Health. 2019 Mar 19;4(2):e001334corr1.


Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain® Line Probe Assay in Southern provinces, Zimbabwe.

Timire C, Sandy C, Kumar AMV, Ngwenya M, Murwira B, Takarinda KC, Harries AD.

Int J Infect Dis. 2019 Apr;81:236-243. doi: 10.1016/j.ijid.2019.02.007. Epub 2019 Feb 15.


How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and treatment clinics in Harare city, Zimbabwe?

Takarinda KC, Choto R, Sandy C, Apollo T, Duri C, Dube F, Mpofu A, Timire C, Mugurungi O, Makaza V, Tapera R, Harries AD.

Trans R Soc Trop Med Hyg. 2018 Oct 1;112(10):450-457. doi: 10.1093/trstmh/try073.


How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?

Timire C, Takarinda KC, Harries AD, Mutunzi H, Manyame-Murwira B, Kumar AMV, Sandy C.

Trans R Soc Trop Med Hyg. 2018 Jun 1;112(6):285-293. doi: 10.1093/trstmh/try054.

Supplemental Content

Loading ...
Support Center